Creyos
Cambridge Brain Sciences is a leading web-based platform for the assessment of cognitive function, built for healthcare practitioners and researchers.
Find out more at cambridgebrainsciences.com. Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows researchers and healthcare providers to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires.
10/08/2026
🖥️ Did you know Creyos reports can sync straight to the patient's chart?
Creyos integrates with Epic, eClinicalWorks, athenahealth, and AdvancedMD, among other EHRs.
After a one-time setup, completed cognitive and behavioral health reports arrive in the chart automatically, with no downloading, scanning, or uploading by hand.
Creyos Director of Product Anthony Chung walks through how the integrations work and what they change for a practice.
Read more: https://hubs.li/Q04y2q_y0
10/07/2026
đź§ Inattention on a repetitive computer task can be associated with ADHD. It can also reflect anxiety, depression, sleep deprivation, or the effects of a sedative medication.
That overlap in presentation impacts how clinicians interpret continuous performance tests, such as the T.O.V.A., in an ADHD assessment.
A new article looks at what these results can tell you about ADHD, and what else belongs alongside them in a complete evaluation.
Read more: https://hubs.li/Q04y2pZ30
10/06/2026
đź§ What does it take to make brain health a more routine part of healthcare?
That question is front and center at the Alzheimer's Association Health Care Summit, where Creyos Chief Marketing Officer Erin Smith is joining the conversation this week.
Just this morning, the Alzheimer’s Association announced its new Brain Health & Quality Care Initiative, aimed at helping health systems integrate brain health and high-quality dementia care into everyday clinical practice, with an initial focus on primary care.
That’s where the conversation gets especially interesting. How do we make cognitive assessment practical, accessible, and useful enough to become a routine part of care?
We’re excited to see that question getting more attention, and to be part of the conversation at the Summit.
https://hubs.li/Q04zmTyL0
09/29/2026
🧠⚕️ Dementia begins as a breakdown in large-scale brain networks 5 to 10 years before obvious symptoms appear.
Health systems route those patients into neurology and geriatrics queues that stretch for months, which defers care during the window when intervention matters most.
One multi-state integrated delivery network redesigned that pathway and moved objective cognitive assessment into primary care.
Our white paper covers:
👉 the science of the detection window
👉 their selection criteria and rollout blueprint
👉 and the financial case under both fee-for-service and value-based care.
The earlier you know, applied at system scale.
Get the white paper: https://hubs.li/Q04y2nwP0
09/28/2026
Awareness is an important part of changing the future of Alzheimer’s and dementia, opening the door to earlier identification, more proactive care, and better support along the care journey.
🧠Following World Alzheimer’s Day, those conversations feel especially timely.
On October 6-7, Erin Smith, Chief Marketing Officer at Creyos, will be in Houston for the Alzheimer's Association Health Care Summit: Advancing Quality and Innovation.
We’re looking forward to conversations about what it takes to move brain health forward, from awareness to meaningful action in everyday care.
📍 Houston | October 6-7
If you're attending, be sure to say hello!
09/22/2026
đź§ An estimated 15.5 million U.S. adults had an ADHD diagnosis in 2023, according to the CDC. Roughly half were diagnosed as adults.
Each diagnosis initiates years of follow-up:
👉 Is the medication working?
👉 Should the dose change?
👉 Is a shift in symptoms a treatment response, a bad week, or something else?
Most practices answer those questions with rating scales and self-report.
Our latest article looks at how Creyos supports monitoring ADHD over time with objective cognitive data, from baseline through follow-up: https://hubs.ly/Q04y2bQW0
09/21/2026
đź’ś Today is World Alzheimer's Day, and this year's theme from Alzheimer's Disease International focuses on the value of an earlier diagnosis.
In the US, more than half of older adults diagnosed with dementia receive that diagnosis from a primary care physician. It often happens in a visit of about 18 minutes that also covers many other health concerns.
Our ebook, Confronting the Dementia Crisis, was written for primary care teams. It reviews current best practices for assessing MCI and dementia and includes a checklist for assessing practice readiness.
👉 Download the free ebook here:
https://hubs.li/Q04x-VL10
09/18/2026
⚕️ Primary care physicians deliver difficult news all the time. Cancer, heart failure, stroke risk, end-of-life care.
A dementia diagnosis is different. It touches memory, judgment, independence, family relationships, and a person's sense of self at once, which is why it cannot be treated as a single disclosure moment.
Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, writes about the conversation itself:
👉 who should be in the room
👉 how to be honest and still leave room for hope
👉 and how the conversation changes with the stage of disease
Read it here: https://hubs.li/Q04xTBxl0
09/16/2026
This fall, we’re looking forward to being part of important conversations about what’s next for dementia detection and care.
Across all three events, our focus is the same: how healthcare organizations can identify cognitive change earlier, create clearer pathways from screening to assessment, and better support patients throughout the dementia care journey.
This October, you can find us at:
📍 AMGA Integration Summit: October 5–7 | Washington, DC
📍 Alzheimer’s Association Health Care Summit: October 6–7 | Houston, TX
📍 AAN Fall Conference: October 9–11 | Las Vegas, NV
If you’ll be attending, we’d love to connect.
09/15/2026
đź’Š Many older adults living with cognitive impairment take at least one anticholinergic medication, and higher burden independently predicts worse cognition.
Anticholinergics block acetylcholine signaling, the same pathway cholinesterase inhibitors work to increase. A medication list can end up internally contradictory, with one drug prescribed to support cognition and another working against it.
Screening for cognitive impairment in primary care can help surface these contributors, and reviewing the medication list is one of the things you can do once you know.
Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, walks through a practical deprescribing process.
Read it here: https://hubs.li/Q04xBPJ90
Click here to claim your Sponsored Listing.
Category
Contact the business
Telephone
Website
Address
214 King Street W. Suite 210
Toronto, ON
M5H3S6
Alerts
Be the first to know and let us send you an email when Creyos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.